75 related articles for article (PubMed ID: 7961561)
1. Clozapine produces potent antidopaminergic effects anatomically specific to the mesolimbic system.
Gardner EL; Chen J; Paredes W
J Clin Psychiatry; 1994 Sep; 55 Suppl B():15-22. PubMed ID: 7961561
[TBL] [Abstract][Full Text] [Related]
2. Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.
Gardner EL; Walker LS; Paredes W
Psychopharmacology (Berl); 1993; 110(1-2):119-24. PubMed ID: 7870870
[TBL] [Abstract][Full Text] [Related]
3. Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine's SCVAR-inhibiting action.
Blessing WW; Ootsuka Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):328-36. PubMed ID: 17055139
[TBL] [Abstract][Full Text] [Related]
4. Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.
Gardner EL; Seeger TF
Biol Psychiatry; 1983 Dec; 18(12):1357-62. PubMed ID: 6661466
[TBL] [Abstract][Full Text] [Related]
5. [Clinical psychopharmacology: the example of clozapine (Leponex)].
Péré JJ
Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
[TBL] [Abstract][Full Text] [Related]
6. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
7. Clozapine: a hypothesised mechanism for its unique clinical profile.
Bunney BS
Br J Psychiatry Suppl; 1992 May; (17):17-21. PubMed ID: 1418885
[TBL] [Abstract][Full Text] [Related]
8. Clozapine's mechanisms of action: non-dopaminergic activity rather than anatomical selectivity.
Lidsky TI; Banerjee SP
Neurosci Lett; 1992 May; 139(1):100-3. PubMed ID: 1407675
[TBL] [Abstract][Full Text] [Related]
9. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
10. Clozapine's anti-acetylcholine property modulates its antistereotypic action in the mesolimbic system.
Al-Shabibi UM; Doggett NS
J Pharm Pharmacol; 1980 May; 32(5):359-61. PubMed ID: 6104704
[No Abstract] [Full Text] [Related]
11. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-HT3-like receptors in the action of clozapine.
Wang RY; Ashby CR; Edwards E; Zhang JY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():23-6. PubMed ID: 7961566
[TBL] [Abstract][Full Text] [Related]
13. Increase in extracellular dopamine levels during clozapine-induced potentiation in the hippocampal dentate gyrus of chronically prepared rabbits.
Kubota T; Jibiki I; Ishikawa A; Kawamura T; Kurokawa S; Wang M
Can J Physiol Pharmacol; 2008 May; 86(5):249-56. PubMed ID: 18432285
[TBL] [Abstract][Full Text] [Related]
14. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
15. Limbic-prefrontal connectivity and clozapine.
Knable MB; Weinberger DR
J Clin Psychiatry; 1994 Sep; 55 Suppl B():70-3. PubMed ID: 7961578
[TBL] [Abstract][Full Text] [Related]
16. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system.
Ortiz J; Fitzgerald LW; Charlton M; Lane S; Trevisan L; Guitart X; Shoemaker W; Duman RS; Nestler EJ
Synapse; 1995 Dec; 21(4):289-98. PubMed ID: 8869159
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological actions of the atypical antipsychotic drug clozapine: a review.
Ashby CR; Wang RY
Synapse; 1996 Dec; 24(4):349-94. PubMed ID: 10638826
[TBL] [Abstract][Full Text] [Related]
18. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
[TBL] [Abstract][Full Text] [Related]
19. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
Ewald HL; Mors NP; Rosenberg R
Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
[TBL] [Abstract][Full Text] [Related]
20. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
Schwieler L; Engberg G; Erhardt S
Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
